Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$465M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$268M |
| 3 |
Verizon
VZ
|
+$239M |
| 4 |
Microsoft
MSFT
|
+$212M |
| 5 |
Apple
AAPL
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$421M |
| 2 |
Becton Dickinson
BDX
|
+$213M |
| 3 |
Home Depot
HD
|
+$191M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$132M |
| 5 |
Broadcom
AVGO
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.96% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
BioAtla
BCAB
$5.46M
| $2.33M | ﹤0.01% |
2,371
+154
| +7% | +$197K |
|
2652
MediaAlpha
MAX
$758M
| $2.33M | ﹤0.01% |
150,758
+3,594
| +2% | +$60K |
|
2653
RPC Inc
RES
$1.24B
| $2.32M | ﹤0.01% |
511,664
-886
| -0.2% | -$4.35K |
|
2654
Warby Parker
WRBY
$3.28B
| $2.32M | ﹤0.01% |
+49,898
| New | +$2.6M |
|
2655
KRONOS Worldwide
KRO
$693M
| $2.32M | ﹤0.01% |
154,760
+2,247
| +1% | +$31.4K |
|
2656
Arlo Technologies
ARLO
$1.6B
| $2.31M | ﹤0.01% |
220,649
+9,224
| +4% | +$72K |
|
2657
Weibo
WB
$2B
| $2.31M | ﹤0.01% |
74,627
+2,323
| +3% | +$94.4K |
|
|
CLVS
2658
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.31M | ﹤0.01% |
851,622
+105,553
| +14% | +$390K |
|
|
VLD
2659
DELISTED
Velo3D, Inc.
VLD
| $2.29M | ﹤0.01% |
+8,395
| New | +$2.78M |
|
2660
Duluth Holdings
DLTH
$155M
| $2.29M | ﹤0.01% |
151,068
| – | – |
|
2661
BlueLinx
BXC
$422M
| $2.29M | ﹤0.01% |
23,933
+619
| +3% | +$41.9K |
|
2662
Oppenheimer Holdings
OPY
$1.14B
| $2.29M | ﹤0.01% |
49,277
-15,115
| -23% | -$745K |
|
2663
Treace Medical Concepts
TMCI
$280M
| $2.28M | ﹤0.01% |
122,456
+41,867
| +52% | +$864K |
|
|
AERI
2664
DELISTED
Aerie Pharmaceuticals
AERI
| $2.28M | ﹤0.01% |
324,982
+27,597
| +9% | +$289K |
|
2665
OneWater Marine
ONEW
$204M
| $2.27M | ﹤0.01% |
37,154
-1,432
| -4% | -$70K |
|
2666
Genco Shipping & Trading
GNK
$1.11B
| $2.27M | ﹤0.01% |
141,524
+58,238
| +70% | +$946K |
|
|
GBIO
2667
DELISTED
Generation Bio
GBIO
| $2.26M | ﹤0.01% |
31,858
+1,367
| +4% | +$239K |
|
2668
Dyne Therapeutics
DYN
$4.7B
| $2.24M | ﹤0.01% |
188,559
+4,376
| +2% | +$61.5K |
|
2669
Offerpad Solutions
OPAD
$18.3M
| $2.24M | ﹤0.01% |
+2,334
| New | +$2.68M |
|
2670
Annexon
ANNX
$834M
| $2.24M | ﹤0.01% |
194,952
+4,025
| +2% | +$65K |
|
2671
Rigel Pharmaceuticals
RIGL
$681M
| $2.23M | ﹤0.01% |
84,293
+906
| +1% | +$27.3K |
|
2672
Uranium Energy
UEC
$4.75B
| $2.23M | ﹤0.01% |
664,314
+83,782
| +14% | +$322K |
|
2673
TAL Education Group
TAL
$6.93B
| $2.22M | ﹤0.01% |
564,469
-20,595
| -4% | -$93.1K |
|
|
BDSI
2674
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $2.22M | ﹤0.01% |
715,184
+60,887
| +9% | +$205K |
|
|
WSR
2675
DELISTED
Whitestone REIT
WSR
| $2.22M | ﹤0.01% |
218,731
-135,129
| -38% | -$1.32M |
|
Similar funds
Charles Schwab's Q4 2021 Portfolio in Review
As of Q4 2021, Charles Schwab held 3,647 positions worth $339B, up 11% from $306B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab's Q4 2021 filing shows 148 new, 2,572 increased, 501 reduced and 58 closed positions. Its largest new stake was Kyndryl: 2,951,149 shares worth $53.4M. The largest sale was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, an estimated $421M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2021 buy was Kyndryl: 2,951,149 shares worth $53.4M.
- Charles Schwab added most to State Street SPDR Portfolio Short Term Treasury ETF in Q4 2021, an estimated $465M increase.
- Charles Schwab's biggest Q4 2021 reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, cutting an estimated $421M.
- Charles Schwab fully exited Kansas City Southern in Q4 2021, selling an estimated $113M.
- Charles Schwab's ten largest holdings make up 18% of its $339B portfolio in Q4 2021.
- Charles Schwab opened 148 new positions and closed 58 in Q4 2021.
- Charles Schwab's portfolio value rose 11% quarter-over-quarter to $339B.
Based on Charles Schwab's 13F filing for Q4 2021, filed 11 Feb 2022.